SINOPHARM GROUP Ownership

SHTDY Stock  USD 11.91  0.08  0.67%   
SINOPHARM GROUP LTD shows a total of 624.13 Million outstanding shares. About 99.99 % of SINOPHARM GROUP outstanding shares are held by general public with 0.01 % by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in pink sheets such as SINOPHARM GROUP in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of SINOPHARM GROUP, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in SINOPHARM GROUP LTD. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

SINOPHARM Pink Sheet Ownership Analysis

The company has price-to-book ratio of 0.9. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. SINOPHARM GROUP LTD last dividend was issued on the 24th of June 2022. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the Peoples Republic of China. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd. Sinopharm is traded on OTC Exchange in the United States.The quote for SINOPHARM GROUP LTD is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about SINOPHARM GROUP LTD contact the company at 86 21 2305 2666 or learn more at https://www.sinopharmgroup.com.cn.

SINOPHARM GROUP Outstanding Bonds

SINOPHARM GROUP issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. SINOPHARM GROUP LTD uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most SINOPHARM bonds can be classified according to their maturity, which is the date when SINOPHARM GROUP LTD has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for SINOPHARM Pink Sheet Analysis

When running SINOPHARM GROUP's price analysis, check to measure SINOPHARM GROUP's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SINOPHARM GROUP is operating at the current time. Most of SINOPHARM GROUP's value examination focuses on studying past and present price action to predict the probability of SINOPHARM GROUP's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SINOPHARM GROUP's price. Additionally, you may evaluate how the addition of SINOPHARM GROUP to your portfolios can decrease your overall portfolio volatility.